Pharmacy - Antimicrobials News & Articles

621 Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital BMC Infectious Diseases, March 6, 2013    Clinical Article

622 Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia Antimicrobial Agents and Chemotherapy, March 6, 2013    Clinical Article

623 Antimicrobial Susceptibility and Resistance Patterns among Helicobacter pylori Strains from The Gambia, West Africa Antimicrobial Agents and Chemotherapy, March 6, 2013    Review Article

624 Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials Clinical Therapeutics, March 5, 2013    Clinical Article

625 Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C Infection Antimicrobial Agents and Chemotherapy, March 5, 2013    Review Article

626 Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort Antiviral Therapy , March 5, 2013    Clinical Article

627 Antifungal therapy: current concepts and evidence-based management Current Medical Research and Opinion, March 4, 2013    Review Article

628 Larch arabinogalactan effects on reducing incidence of upper respiratory infections Current Medical Research and Opinion, March 4, 2013    Clinical Article

629 Dissociation of the Pharmacological Effects of THC by mTOR Blockade Neuropsychopharmacology, March 4, 2013    Review Article

630 Tigecycline-Induced Acute Pancreatitis with Rechallenge: A Case Report Journal of Pharmacy Technology, March 4, 2013

631 What to do about multidrug-resistant gonorrhea Full Text Formulary , March 4, 2013    Clinical Article

632 Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor Transplant International, March 4, 2013    Review Article

633 Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy AIDS, March 4, 2013    Clinical Article

634 The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis AIDS, March 1, 2013    Clinical Article

635 Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults Antimicrobial Agents and Chemotherapy, March 1, 2013    Clinical Article

636 Varicella Zoster Virus-Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications Clinical Infectious Diseases, March 1, 2013    Clinical Article

637 Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant {beta}-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment Antimicrobial Agents and Chemotherapy, March 1, 2013    Clinical Article

638 Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study Full Text BMC Pharmacology & Toxicology, March 1, 2013    Clinical Article

639 Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects Antimicrobial Agents and Chemotherapy, March 1, 2013    Clinical Article

640 Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents Antimicrobial Agents and Chemotherapy, March 1, 2013    Clinical Article

1 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections Cochrane Reviews, March 29, 2013    Review Article

2 Telavancin and Daptomycin activity against methicillin-resistant Staphylococcus aureus strains after vancomycin resistance selection in vitro Journal of Medical Microbiology, April 22, 2013

3 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Clinical Infectious Diseases, April 1, 2013

4 Infective Endocarditis New England Journal of Medicine, April 12, 2013

5 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

6 Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection European Journal of Clinical Pharmacology, April 3, 2013

7 Effect of Azithromycin on Anticoagulation-Related Outcomes in Geriatric Patients Receiving Warfarin Clinical Therapeutics, April 22, 2013

8 Antifungal Therapy for Invasive Aspergillosis U.S. Pharmacist, April 26, 2013    Free full text

9 Infective Endocarditis New England Journal of Medicine, April 24, 2013    Review Article

10 Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, April 23, 2013

11 Update on the Antimicrobial Management of Foot Infections in Patients With Diabetes Clinical Diabetes, April 18, 2013    Free full text    Review Article

12 Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents Clinical Microbiology Reviews, April 4, 2013

13 Is It Time To Replace Vancomycin In The Treatment Of MRSA Infections Clinical Infectious Diseases, April 4, 2013

14 Clinical Trial: Comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole vs. cephalexin alone for treatment of uncomplicated cellulitis: A randomized controlled trial Clinical Infectious Diseases, March 21, 2013

15 Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials International Journal of Antimicrobial Agents, April 23, 2013    Evidence Based Medicine

16 Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections European Journal of Clinical Microbiology & Infectious Diseases, April 5, 2013

17 Tigecycline: an update Diagnostic Microbiology and Infectious Disease, February 5, 2013

18 Effect of adequate single-drug versus combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections. A post hoc analysis of a prospective cohort Clinical Infectious Diseases, April 17, 2013

19 Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies Expert Review of Anti-infective Therapy, April 19, 2013

20 Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia International Journal of Antimicrobial Agents, April 19, 2013